Option Care Health (NASDAQ:OPCH) Releases FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.590-1.690 for the period, compared to the consensus EPS estimate of 1.330. The company issued revenue guidance of $5.3 billion-$5.5 billion, compared to the consensus revenue estimate of $5.3 billion.

Wall Street Analysts Forecast Growth

Several brokerages have commented on OPCH. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research boosted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. JPMorgan Chase & Co. boosted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday. Finally, UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $33.00.

Remove Ads

Option Care Health Price Performance

Shares of OPCH stock traded down $0.25 during trading hours on Friday, hitting $34.01. The company's stock had a trading volume of 1,610,533 shares, compared to its average volume of 1,591,663. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.85. The stock has a market cap of $5.62 billion, a price-to-earnings ratio of 28.58, a P/E/G ratio of 2.30 and a beta of 1.33. The business has a fifty day moving average of $29.61 and a 200-day moving average of $28.18.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.